Detection of a delayed Treatment of urgent ophthalmologic Treatment during the SARS-CoV-2 pandemic (COVID-19)

Detection of a delayed Treatment of urgent ophthalmologic Treatment during the SARS-CoV-2 pandemic (COVID-19) - COVID-19 DETOUR: Delayed Treatment of urgent ophthalmologic treatment during SARS-CoV-2 pandemic

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021630

Enrollment

Registered

2020-05-06

Start date

2020-05-08

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H33.0 H34.8

Interventions

Group 1: Interview group: Patients who are urgently hospitalized for an ophthalmic emergency are - informed consent provided - interviewed for factors which may have delayed diagnosis or treatment by

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: indication for an immediate or urgent Admission as an inpatient due to an ophthalmologic disease.

Exclusion criteria

Exclusion criteria: planned Admission for elective treatment

Design outcomes

Primary

Measure	Time frame
Rate of patients indicating a delay in Treatment due to COVID-19 pandemic.	—

Secondary

Measure	Time frame
Rates of patients indicating reasons concerning a) their own Motivation, b) the accessibility of a further diagnostic/Treatment, and c) organisational Problems for a delayed care.	—

Countries

Germany

Contacts

Public ContactChristoph Ehlken

Klinik für Augenheilkunde, UKSH Kiel

christoph.ehlken@uksh.de043150024231

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 21, 2026